We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Merck and Samsung Bioepis Enter Biosimilars Agreement

News   Feb 21, 2013

 
Merck and Samsung Bioepis Enter Biosimilars Agreement
 
 
 

RELATED ARTICLES

Antibiotics Generated from Wasp Venom

News

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

READ MORE

Emerging Strategies for Treating Opioid-use Disorder

News

Anti-opioid immunopharmacotherapies (e.g., conjugate vaccines) that sequester drug peripherally, preventing opioids from reaching targeted receptors in the brain, have recently emerged as promising therapeutics.

READ MORE

Cancer Vaccine Progress: Potentially Rich Source of Tumor Specific Antigens Identified

News

The immunogenicity and efficacy of tumor specific antigen vaccination for select antigens has been validated in mouse models of cancer. The researchers believe that clinical trials for human cancer vaccines could start within the next 2-3 years.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE